Skip to main content

Anika Therapeutics, Inc 10-K for FY2020

Anika Therapeutics, Inc. (ANIK)

10-K 2021-03-05 For: 2020-12-31
View Original
Added on April 06, 2026

About this 10-K

Anika Therapeutics, Inc filed this 10-K on March 5, 2021, covering the fiscal year ended December 31, 2020 (FY2020).

Headline figures

Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$130.46M
up 13.8% from $114.61M a year earlier
Net loss
$23.98M
compared with net income of $27.19M a year earlier
Diluted EPS
-$1.69
compared with $1.89 a year earlier